- All of the following are established pathophysiologic mechanisms contributing to heart failure with reduced ejection fraction (HFrEF) EXCEPT:
Answer: Titin protein mutations leading to pathologically decreased myocardial passive stiffness.
When analyzing heart failure with reduced ejection fraction (HFrEF), focus on mechanisms that impair the heart's ability to contract and pump blood effectively. HFrEF results from problems with systolic function - the heart's squeezing ability.
Option D describes the correct answer because titin protein mutations that decrease myocardial passive stiffness would actually make the heart more compliant and easier to fill. This mechanism contributes to heart failure with preserved ejection fraction (HFpEF), not reduced ejection fraction. In HFpEF, the heart pumps normally but has trouble relaxing and filling due to increased stiffness.
The other options all represent established HFrEF mechanisms. Option A describes how myocardial infarction destroys contractile tissue, directly reducing the heart's pumping capacity - a classic cause of systolic dysfunction. Option B explains how chronic hypertension forces the heart to work harder against increased resistance (afterload), eventually leading to myocyte death and weakened contraction. Option C demonstrates how aortic regurgitation creates volume overload, causing the ventricle to dilate and stretch beyond its optimal length-tension relationship, impairing contractile efficiency.
Remember this key distinction: HFrEF involves problems with contraction (systolic dysfunction), while HFpEF involves problems with relaxation and filling (diastolic dysfunction). When you see decreased stiffness or improved compliance, think HFpEF. When you see anything that damages contractile tissue, increases workload, or impairs the heart's squeezing mechanism, think HFrEF.
- In the progression of systolic heart failure following a myocardial infarction, the initial drop in cardiac output triggers neurohormonal activation, including the renin-angiotensin-aldosterone system (RAAS). How does the resulting chronic elevation of angiotensin II contribute to maladaptive ventricular remodeling?
Answer: By directly stimulating myocyte hypertrophy and interstitial fibrosis via AT1 receptor activation.
While initially compensatory, chronic RAAS activation is detrimental. Angiotensin II has direct trophic effects on the heart, mediated by AT1 receptors. It promotes myocyte hypertrophy and stimulates cardiac fibroblasts to produce excess collagen, leading to interstitial fibrosis. This remodeling process further stiffens the ventricle and contributes to the progressive decline of cardiac function in systolic heart failure.
- A pressure-volume loop analysis is performed on a patient with heart failure. The loop shows a normal end-systolic volume and a preserved ejection fraction. However, the end-diastolic pressure-volume relationship (EDPVR) is shifted upward and to the left compared to normal. This finding is most indicative of:
Answer: Decreased left ventricular compliance.
The EDPVR represents the passive stiffness (or compliance) of the ventricle during filling. An upward and leftward shift of this curve means that for any given diastolic volume, the pressure is significantly higher. This is the definition of decreased ventricular compliance or increased stiffness, which is the fundamental mechanical defect in diastolic heart failure (HFpEF).
- An experimental model of heart failure is created, resulting in the pressure-volume loop changes shown in the accompanying figure. Compared to the normal loop, the heart failure loop demonstrates a rightward shift of the loop, a significantly increased end-systolic volume, and a downward shift of the end-systolic pressure-volume relationship (ESPVR). This pattern is most consistent with which underlying mechanism? Look at the figure provided.
Answer: A primary decrease in myocardial contractility.
The key findings in the pressure-volume loop are characteristic of systolic heart failure. A significantly increased end-systolic volume indicates the ventricle is failing to empty properly. The downward and rightward shift of the ESPVR line is the definitive sign of decreased contractility (impaired inotropy). The ventricle cannot generate as much pressure for a given volume, which is the core defect in systolic dysfunction.
- A patient with severe aortic stenosis develops symptoms of heart failure. An echocardiogram shows marked concentric left ventricular hypertrophy and an LVEF of 60%. The development of heart failure in this patient is primarily a consequence of:
Answer: Diastolic dysfunction due to impaired ventricular relaxation and increased stiffness.
When you encounter aortic stenosis with heart failure despite normal ejection fraction, think about the difference between systolic and diastolic heart failure. The key insight is understanding how chronic pressure overload affects ventricular function.
In severe aortic stenosis, the left ventricle faces enormous resistance to ejection, creating chronic pressure overload. To maintain stroke volume, the heart develops concentric hypertrophy - the walls thicken inward without chamber enlargement. While this initially preserves pumping ability (hence the normal 60% ejection fraction), the thickened, stiff ventricle becomes increasingly difficult to fill during diastole.
Option A is correct because the concentric hypertrophy creates a non-compliant ventricle that resists filling, leading to elevated filling pressures and diastolic dysfunction. Heart failure occurs despite preserved systolic function.
Option B incorrectly suggests systolic dysfunction, but the normal ejection fraction indicates preserved contractility. While myocyte apoptosis may occur later, it's not the primary mechanism here.
Option C confuses aortic stenosis with aortic regurgitation. Stenosis causes pressure overload and concentric hypertrophy, not volume overload and eccentric hypertrophy. Post-stenotic dilation doesn't cause volume overload.
Option D, while coronary perfusion can be compromised in severe hypertrophy, isn't the primary mechanism of heart failure in this scenario with preserved ejection fraction.
Remember: In pressure overload conditions like aortic stenosis, think "diastolic dysfunction first" when you see heart failure with preserved ejection fraction. The stiff, hypertrophied ventricle can't fill properly, even though it contracts normally.
- A patient with a known diagnosis of HFrEF (LVEF 30%) develops atrial fibrillation with a rapid ventricular response (RVR) at 150 bpm. Why is this arrhythmia particularly detrimental to their cardiac output?
Answer: The rapid heart rate drastically reduces diastolic filling time for a ventricle that is highly dependent on preload to maintain stroke volume.
When you encounter questions about heart failure with reduced ejection fraction (HFrEF) and new arrhythmias, focus on how the failing heart depends on specific mechanisms to maintain adequate cardiac output.
In HFrEF, the ventricle is already operating at maximum capacity with impaired contractility. Since cardiac output equals stroke volume times heart rate, and stroke volume is compromised, the heart relies heavily on optimizing filling time and preload to squeeze out whatever stroke volume it can generate. The Frank-Starling mechanism becomes crucial—the dilated ventricle needs adequate filling to stretch the sarcomeres to their optimal length.
When atrial fibrillation with RVR develops, the drastically shortened diastolic filling time becomes the primary problem. At 150 bpm, diastole is severely truncated, preventing the ventricle from filling adequately. Since this failing heart is highly preload-dependent, reduced filling directly translates to dramatically reduced stroke volume and cardiac output collapse. This makes A correct.
B is wrong because while loss of atrial kick (contributing ~20-30% of ventricular filling) matters, it's not the primary mechanism—the shortened filling time is far more significant. C is incorrect because atrial fibrillation doesn't cause ventricular dyssynchrony; the ventricles still contract synchronously through the normal conduction system. D misrepresents the Bowditch effect, which involves increased contractility with higher rates, but this positive effect is overwhelmed by the filling time problem in heart failure.
Remember: In HFrEF + tachyarrhythmia questions, always consider diastolic filling time as the key limiting factor for cardiac output.
- Which statement accurately distinguishes the role of left ventricular hypertrophy in systolic versus diastolic heart failure?
Answer: In diastolic HF, concentric hypertrophy is a primary pathogenic factor causing stiffness, whereas in systolic HF, eccentric hypertrophy is a compensatory response that becomes maladaptive.
This choice correctly identifies the distinct roles of hypertrophy. In diastolic HF, concentric hypertrophy (thick walls, normal cavity), driven by pressure overload, is a primary cause of the ventricular stiffness that impairs filling. In systolic HF, eccentric hypertrophy (dilated cavity, thinned walls), driven by volume overload or post-MI remodeling, is initially a compensatory mechanism (via Frank-Starling) that becomes maladaptive by increasing wall stress and energy demand.
- Which of the following patterns of cardiac remodeling is the most direct cause of heart failure with preserved ejection fraction (HFpEF)?
Answer: Concentric hypertrophy with an increased ratio of wall thickness to chamber radius.
Concentric hypertrophy is the structural hallmark of many forms of HFpEF. It is an adaptation to pressure overload (e.g., hypertension) where myocytes thicken, increasing the ventricular wall thickness relative to the chamber radius. This geometric change significantly increases ventricular stiffness and impairs diastolic relaxation and filling, which is the primary defect in HFpEF.
- A patient with chronic hypertension develops heart failure. Biopsy of the ventricular myocardium shows extensive interstitial fibrosis and an increase in collagen cross-linking. This structural change would most directly impair which phase of the cardiac cycle and contribute to which type of heart failure?
Answer: Diastolic filling; Diastolic HF.
Interstitial fibrosis and collagen cross-linking significantly increase the passive stiffness of the myocardium. This directly impedes the ability of the ventricle to relax and expand to accept blood during diastole. This impairment of ventricular filling is the cardinal feature of diastolic dysfunction, which leads to diastolic heart failure (HFpEF). While relaxation is impaired, the most significant functional consequence is on the overall filling phase.
- A clinician is evaluating two patients with classic symptoms of heart failure. Patient A has an LVEF of 35%. Patient B has an LVEF of 55%. Which of the following pathophysiological findings is most likely to be a prominent feature in Patient A but not in Patient B?
Answer: A significant increase in left ventricular end-systolic volume.
Patient A has HFrEF (systolic failure), while Patient B has HFpEF (diastolic failure). The defining hemodynamic abnormality in systolic heart failure is impaired contractility, resulting in the ventricle's failure to empty effectively. This leads to a significant increase in the amount of blood left in the ventricle after contraction (end-systolic volume). In diastolic heart failure, the primary problem is filling, and the end-systolic volume is typically normal or near-normal.
- A patient with well-compensated diastolic heart failure (HFpEF) and concentric hypertrophy is asked to walk briskly on a treadmill. Which of the following mechanisms best explains why they rapidly develop dyspnea?
Answer: The exercise-induced tachycardia shortens diastolic filling time, which a non-compliant ventricle cannot tolerate, causing a sharp rise in left atrial pressure.
In HFpEF, the stiff, non-compliant left ventricle requires adequate time to fill. During exercise, the heart rate increases, which shortens the duration of diastole more than systole. This reduced filling time is poorly tolerated, leading to a smaller end-diastolic volume and thus a limited ability to increase stroke volume. Simultaneously, the increased venous return against a stiff ventricle causes a rapid rise in left atrial and pulmonary venous pressures, leading to acute pulmonary congestion and dyspnea.
- A medical student incorrectly states that 'since the ejection fraction is preserved in diastolic heart failure, the patient's stroke volume must be normal.' Why is this statement pathophysiologically incorrect?
Answer: Stroke volume is often reduced because the end-diastolic volume is abnormally low due to impaired filling.
When evaluating heart failure with preserved ejection fraction (HFpEF), you need to understand that ejection fraction and stroke volume are related but distinct measurements that can change independently under pathological conditions.
The correct answer is D because diastolic heart failure fundamentally involves impaired ventricular filling. The stiff, non-compliant ventricle cannot adequately relax during diastole, resulting in a reduced end-diastolic volume (EDV). Since stroke volume equals EDV minus end-systolic volume (ESV), when EDV decreases significantly while ESV remains relatively unchanged, stroke volume falls. The ejection fraction (EF = stroke volume ÷ EDV) can remain normal because both the numerator (stroke volume) and denominator (EDV) are proportionally reduced.
Option A incorrectly describes the ejection fraction formula - it's stroke volume divided by end-diastolic volume, not end-systolic volume. Option B misrepresents the pathophysiology; the Frank-Starling mechanism isn't "suppressed" in diastolic failure, and ejection fraction measurements remain valid. The mechanism simply operates on a shifted curve due to altered preload conditions. Option C contradicts the actual pathophysiology - in diastolic failure, end-systolic volume typically remains normal or may even be reduced, not increased.
Remember this key distinction: ejection fraction measures the percentage of blood pumped out, while stroke volume measures the absolute amount. In HFpEF, think "small but efficient" - the heart ejects a normal percentage of a smaller volume, resulting in reduced cardiac output despite preserved ejection fraction.
- Both systolic and diastolic heart failure are associated with elevated levels of B-type natriuretic peptide (BNP). Which statement provides the most accurate explanation for the significant BNP elevation seen in a patient with pure diastolic dysfunction (HFpEF)?
Answer: The stiff, non-compliant ventricle experiences high wall stress during diastolic filling, which is the primary stimulus for BNP release.
When you encounter questions about BNP elevation in heart failure, focus on the fundamental stimulus for its release: ventricular wall stress. BNP is primarily secreted by ventricular myocytes when they experience mechanical stretch or increased wall tension.
In HFpEF (heart failure with preserved ejection fraction), the ventricle becomes stiff and non-compliant due to processes like fibrosis, hypertrophy, or infiltrative disease. During diastolic filling, this rigid ventricle cannot accommodate blood volume easily, creating high intracavitary pressures. According to LaPlace's law, wall stress increases with both pressure and chamber size. Even though the chamber may not be dramatically enlarged in HFpEF, the elevated filling pressures create significant wall stress, triggering BNP release. This makes option A correct.
Option B is wrong because HFpEF patients typically have normal or elevated blood pressure, not low arterial pressure. BNP responds to ventricular stretch, not systemic pressure changes. Option C incorrectly identifies the source and mechanism - while atrial stretch can contribute to natriuretic peptide release (specifically ANP), the primary source of BNP elevation in heart failure is ventricular myocytes responding to wall stress, not atrial volume overload. Option D overstates renal dysfunction's role; while kidney disease can reduce BNP clearance, it's not universal in HFpEF, and the primary driver of elevation is increased production due to ventricular stress.
Remember: BNP questions often test whether you understand that mechanical stress on ventricular walls - not just reduced ejection fraction - drives BNP release in all forms of heart failure.
- In comparing the typical invasive hemodynamic profiles of decompensated systolic (HFrEF) and diastolic (HFpEF) heart failure, which of the following patterns is most accurate?
Answer: HFrEF: Low cardiac index, high PCWP, high SVR. HFpEF: Near-normal cardiac index at rest, high PCWP, normal SVR.
When analyzing hemodynamic profiles in heart failure, you need to understand how the underlying pathophysiology drives different compensatory mechanisms in systolic versus diastolic dysfunction.
In HFrEF (systolic heart failure), the heart's pumping ability is severely impaired, leading to a low cardiac index. This triggers intense compensatory vasoconstriction, resulting in high systemic vascular resistance (SVR). Blood backs up into the pulmonary circulation, causing elevated pulmonary capillary wedge pressure (PCWP). In HFpEF (diastolic heart failure), the heart can still contract normally at rest, maintaining a near-normal cardiac index, but filling is impaired due to stiffness. This creates high filling pressures (high PCWP), while SVR remains relatively normal since the compensatory vasoconstriction isn't as pronounced.
Answer A correctly captures this pattern: HFrEF shows the classic triad of poor pump function (low cardiac index), congestion (high PCWP), and compensatory vasoconstriction (high SVR), while HFpEF shows preserved systolic function (near-normal cardiac index) with impaired filling (high PCWP) but less systemic compensation (normal SVR).
Answer B incorrectly suggests HFpEF has low PCWP and low SVR, missing the key feature of elevated filling pressures. Answer C completely reverses the profiles. Answer D incorrectly shows low PCWP in HFrEF, which contradicts the backward failure that defines decompensation.
Remember: HFrEF = "pump problem" with systemic compensation; HFpEF = "filling problem" with preserved contractility. Both show high PCWP when decompensated, but only HFrEF shows the full compensatory response with high SVR.
- In heart failure with preserved ejection fraction (HFpEF), impaired diastolic relaxation is a key feature. Alterations in which of the following intracellular calcium handling proteins is most directly responsible for this impaired lusitropy?
Answer: Reduced activity or expression of the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA2a).
Lusitropy, or myocardial relaxation, is an active, energy-dependent process that largely relies on the re-uptake of cytosolic calcium into the sarcoplasmic reticulum by the SERCA2a pump. In many forms of diastolic dysfunction, the activity or expression of SERCA2a is reduced. This leads to slower removal of calcium from the cytosol, which impairs and prolongs myocyte relaxation, a core mechanism of diastolic heart failure.
- A new investigational drug is found to promote the phosphorylation of phospholamban. In which type of heart failure would this mechanism be most specifically targeted to improve the primary pathophysiologic defect?
Answer: Diastolic heart failure, by improving the rate of myocardial relaxation.
Phospholamban (PLN) is a key regulator of SERCA2a, the pump that returns calcium to the sarcoplasmic reticulum. In its dephosphorylated state, PLN inhibits SERCA2a. Phosphorylation of PLN relieves this inhibition, accelerating calcium re-uptake and thereby enhancing the rate and completeness of myocardial relaxation (lusitropy). This directly addresses the core mechanism of impaired relaxation in diastolic heart failure.
- A patient is diagnosed with restrictive cardiomyopathy due to cardiac amyloidosis. They present with signs of severe heart failure, but their echocardiogram shows a normal ejection fraction. The fundamental mechanism of their heart failure is most similar to that seen in:
Answer: Heart failure associated with long-standing, untreated hypertension.
Restrictive cardiomyopathy, caused by infiltration of the myocardium by substances like amyloid, results in extremely stiff, non-compliant ventricular walls. This severely impairs diastolic filling, leading to HFpEF. This underlying mechanism—impaired filling due to pathologic stiffness—is the same fundamental problem as in the most common form of diastolic heart failure, which is caused by the concentric hypertrophy resulting from long-standing hypertension.
- An S3 gallop is heard in early diastole, while an S4 gallop is heard in late diastole. How do the underlying mechanisms of these two sounds relate to systolic and diastolic heart failure?
Answer: An S3 reflects rapid filling into a dilated, volume-overloaded ventricle (systolic HF); an S4 reflects atrial contraction into a non-compliant ventricle (diastolic HF).
The S3 gallop is generated by the deceleration of blood rushing into a dilated, overly compliant, and volume-overloaded ventricle, a state characteristic of systolic heart failure. The S4 gallop is generated by the forceful contraction of the atrium pushing blood into a pathologically stiff, non-compliant ventricle, which is the hallmark of diastolic dysfunction. Therefore, S3 is associated with systolic HF and S4 with diastolic HF.
- A 72-year-old female with a 20-year history of poorly controlled hypertension complains of exertional dyspnea. Her echocardiogram shows a normal ejection fraction of 58% but reveals significant left ventricular hypertrophy and left atrial enlargement. Which mechanism best explains her symptoms?
Answer: Elevated left ventricular end-diastolic pressure due to decreased ventricular compliance.
This clinical picture is characteristic of diastolic heart failure (HFpEF). Chronic hypertension causes pressure overload, leading to concentric left ventricular hypertrophy. This makes the ventricle stiff and non-compliant, impairing its ability to relax and fill during diastole. Consequently, the left ventricular end-diastolic pressure (LVEDP) rises significantly, which is transmitted backward to the left atrium and pulmonary circulation, causing pulmonary congestion and dyspnea, especially on exertion.
- A 65-year-old male with a history of a large anterior myocardial infarction presents with progressive dyspnea. An echocardiogram reveals a left ventricular ejection fraction (LVEF) of 30% and significant left ventricular dilation. Which of the following best describes the primary pathophysiologic mechanism for his heart failure?
Answer: Impaired myocardial contractility leading to a reduced forward stroke volume.
The patient's history of myocardial infarction, low ejection fraction (<40%), and dilated ventricle are classic features of systolic heart failure (HFrEF). The fundamental mechanism in HFrEF is the loss of functional myocytes, which leads to impaired myocardial contractility (systolic dysfunction). This inability of the ventricle to pump effectively results in a reduced stroke volume and a high end-systolic volume.
